About
PriveBio develops novel biologic therapeutics targeting fibroinflammatory pathways to treat obesity-related cardiorenal and metabolic diseases, aiming to improve patient healthspan and lifespan.
Explore PriveBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.